Coronary Restenosis After Sirolimus-Eluting Stent Implantation-Reference-Cited by-同舟云学术

Coronary Restenosis After Sirolimus-Eluting Stent Implantation

Published:2003-07-22 Issue:3 Volume:108 Page:257-260
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Lemos Pedro A.¹,Saia Francesco¹,Ligthart Jurgen M.R.¹,Arampatzis Chourmouzios A.¹,Sianos Georgios¹,Tanabe Kengo¹,Hoye Angela¹,Degertekin Muzaffer¹,Daemen Joost¹,McFadden Eugene¹,Hofma Sjoerd¹,Smits Pieter C.¹,de Feyter Pim¹,van der Giessen Willem J.¹,van Domburg Ron T.¹,Serruys Patrick W.¹

Affiliation:

1. From Erasmus Medical Center, Thoraxcenter, Rotterdam, the Netherlands.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference6 articles.

1. A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

2. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes

3. Immediate and long-term results of “T” stenting for bifurcation coronary lesions

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of In-stent Restenosis;Indian Journal of Cardiovascular Disease in Women;2023-03-24

2. Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy;Journal of the American Heart Association;2022-11-15

3. Network Meta-analysis of Trials Comparing Intravascular Ultrasound, Optical Coherence Tomography, and Angiography-Guided Technique for Drug-Eluting Stent Implantation;Journal of the Society for Cardiovascular Angiography & Interventions;2022-11

4. Overexpressed VLA-4 on endothelial cell membrane camouflaging the pathological reactive oxygen species responsive prodrug to enhance target therapy for atherosclerosis;Chemical Engineering Journal;2022-08

5. Management of in-stent restenosis;EuroIntervention;2022-06